Athersys Gets $56 Million From Healios In Stem Cell Deal – Seeking Alpha
CNA Finance |
Athersys Gets $56 Million From Healios In Stem Cell Deal
Seeking Alpha The last 6 months have been a difficult period for Athersys (NASDAQ:ATHX) shareholders as shares have declined sharply from a high of $2.63 last fall to a recent low of $1.29. The primary reason for this precipitous decline had been the nagging feeling … Athersys and HEALIOS Announce Binding Letter of Intent to Expand MultiStem® Collaboration |
